Literature DB >> 7947320

Mice homozygous for a null mutation of activin beta B are viable and fertile.

H Schrewe1, M Gendron-Maguire, M L Harbison, T Gridley.   

Abstract

We have made a null mutation in the mouse activin beta B gene by deleting the portion of the gene encoding the proteolytic cleavage site and the majority of the coding region for the mature processed protein. Mice homozygous for this mutation complete embryogenesis and are completely viable. Approximately 40% of the homozygous mutant animals are born with open eyes. Aside from the incompletely penetrant eye defects, histopathological analysis has not revealed any other abnormalities in homozygous mutant animals. Breeding tests have shown that both male and female homozygous mutant animals are fertile.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947320     DOI: 10.1016/0925-4773(94)90094-9

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  15 in total

1.  MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration.

Authors:  Lin Zhang; Maoxian Deng; Ranjani Parthasarathy; Lei Wang; Maureen Mongan; Jeffery D Molkentin; Yi Zheng; Ying Xia
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

2.  Activin modulates the transcriptional response of LbetaT2 cells to gonadotropin-releasing hormone and alters cellular proliferation.

Authors:  Hao Zhang; Janice S Bailey; Djurdjica Coss; Bo Lin; Rie Tsutsumi; Mark A Lawson; Pamela L Mellon; Nicholas J G Webster
Journal:  Mol Endocrinol       Date:  2006-06-13

Review 3.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 4.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

5.  Regulation of muscle mass by follistatin and activins.

Authors:  Se-Jin Lee; Yun-Sil Lee; Teresa A Zimmers; Arshia Soleimani; Martin M Matzuk; Kunihiro Tsuchida; Ronald D Cohn; Elisabeth R Barton
Journal:  Mol Endocrinol       Date:  2010-09-01

6.  Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure.

Authors:  Bernhard H F Weber; Heinrich Schrewe; Laurie L Molday; Andrea Gehrig; Karen L White; Mathias W Seeliger; Gesine B Jaissle; Christoph Friedburg; Ernst Tamm; Robert S Molday
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

7.  Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis.

Authors:  M Wankell; B Munz; G Hübner; W Hans; E Wolf; A Goppelt; S Werner
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

8.  A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing.

Authors:  Maoxian Deng; Wei-Li Chen; Atsushi Takatori; Zhimin Peng; Lin Zhang; Maureen Mongan; Ranjani Parthasarathy; Maureen Sartor; Marian Miller; Jianhua Yang; Bing Su; Winston W-Y Kao; Ying Xia
Journal:  Mol Biol Cell       Date:  2006-06-07       Impact factor: 4.138

9.  Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.

Authors:  Marcin Chrusciel; Susanna Vuorenoja; Bidut Mohanty; Adolfo Rivero-Müller; Xiangdong Li; Jorma Toppari; Ilpo Huhtaniemi; Nafis A Rahman
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

10.  Characterization of two ectrodactyly-associated translocation breakpoints separated by 2.5 Mb on chromosome 2q14.1-q14.2.

Authors:  Dezso David; Bárbara Marques; Cristina Ferreira; Paula Vieira; Alfredo Corona-Rivera; José Carlos Ferreira; Hans van Bokhoven
Journal:  Eur J Hum Genet       Date:  2009-02-18       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.